-transparent.png){kind=logo}
15/60 subjects from one center, who all took part in a multicenter double-blind, placebo-controlled study to evaluate the effect of norfloxacin on acute enteritis, had norfloxacin sensitive strains of Campylobacter jejuni in pre-study stool specimens. Eight of the 15 subjects received active drug. In 3 of these 8, high-level quinolone resistant Campylobacter strains of the same serotype as in pre-treatment samples were isolated 4-90 days after the initiation of treatment.
Related Publications
B Wretlind, and
A Strömberg, and
L Ostlund, and
E Sjögren, and
B Kaijser
February 1994,
Antimicrobial agents and chemotherapy,
B Wretlind, and
A Strömberg, and
L Ostlund, and
E Sjögren, and
B Kaijser
August 1997,
The Journal of antimicrobial chemotherapy,
B Wretlind, and
A Strömberg, and
L Ostlund, and
E Sjögren, and
B Kaijser
July 1995,
The Journal of antimicrobial chemotherapy,
B Wretlind, and
A Strömberg, and
L Ostlund, and
E Sjögren, and
B Kaijser
May 1991,
Antimicrobial agents and chemotherapy,
B Wretlind, and
A Strömberg, and
L Ostlund, and
E Sjögren, and
B Kaijser
April 1992,
The Journal of infectious diseases,
B Wretlind, and
A Strömberg, and
L Ostlund, and
E Sjögren, and
B Kaijser
October 2003,
The Journal of antimicrobial chemotherapy,
B Wretlind, and
A Strömberg, and
L Ostlund, and
E Sjögren, and
B Kaijser
July 1992,
Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
B Wretlind, and
A Strömberg, and
L Ostlund, and
E Sjögren, and
B Kaijser
March 2007,
Research in microbiology,
B Wretlind, and
A Strömberg, and
L Ostlund, and
E Sjögren, and
B Kaijser
October 1991,
Antimicrobial agents and chemotherapy,
B Wretlind, and
A Strömberg, and
L Ostlund, and
E Sjögren, and
B Kaijser
October 2016,
Drug testing and analysis,
